| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
L | | FI | | I/B | Infanrix DTPa-IPV | | 20.20 | 38.40 | 10% | | 8 Wirkstoffe | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | | I/B | Engerix-B 20 | | 23.66 | 42.15 | 10% | | Injektionssuspension: Hepatitidis b viri Antigenum Adnr 20 µg/ml | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Casgevy 4-13 x 10e6 cells/ml | | PA | PA | k.A. | | | Vertex Pharmaceuticals (CH) GmbH | A | FB | | G |  |
| | FI | PI | | Ebvallo | | PA | PA | k.A. | | | Pierre Fabre Pharma SA | A | FB | | G |  |
| | FI | PI | | BILAXIN Ophta 6 mg / ml | 5 ml | PA | PA | k.A. | | Augentropfen: Bilastinum 6 mg/ml | A. Menarini GmbH | D | FB | | G |  |
| | FI | | I/B | Engerix-B 20 | 10 | PA | PA | k.A. | | Injektionssuspension: Hepatitidis b viri Antigenum Adnr 20 µg/ml | GlaxoSmithKline AG | B | FB | | G |  |
| | FI | PI | | Imodium ‐ F - T | 20 Kapsel(n) | 3.87 | 6.85 | 40% | | Kapseln: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / SL / SO | FB | | G |  |
| | FI | PI | | Imodium - T | 60 Kapsel(n) | 9.40 | 26.60 | 40% | | Kapseln: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Incruse Ellipta | 30 Einzeldosen | 34.64 | 54.10 | 10% | | Inhalationspulver: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Incruse Ellipta | 3 x 30 Einzeldosen | 103.00 | 128.45 | 10% | | Inhalationspulver: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | | I/B | Hiberix | Set(s) | 16.16 | 34.00 | 10% | | Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | PI | | Microlax | 4 x 5 ml | 4.15 | 7.65 | 10% | | Klistier: 3 Wirkstoffe | JNTL Consumer Health II (Switzerland) GmbH | D / SL | FB | | G |  |
L | | FI | PI | | Microlax | 12 x 5 ml | 12.45 | 23.00 | 10% | | Klistier: 3 Wirkstoffe | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | FI | PI | | Microlax | 50 x 5 ml | 51.88 | 95.80 | 10% | | Klistier: 3 Wirkstoffe | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | FI | | | Vegzelma 100 mg/4 ml | | 257.57 | 296.55 | 10% | | Infusionskonzentrat: Bevacizumabum 100mg / 4ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | FI | | | Vegzelma 400 mg/16 ml | | 962.84 | 1063.55 | 10% | | Infusionskonzentrat: Bevacizumabum 400mg / 16ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | FI | PI | | D3 VitaCaps 24,000 IU (600 μg) | 6 | 7.65 | 17.55 | 10% | | Weichkapseln: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
L | | FI | PI | | Vitamin D3 Sandoz eco 1000 I.E. | 30 | 1.68 | 3.10 | 10% | | Weichkapseln: Cholecalciferolum 1000 UI | Sandoz Pharmaceuticals AG | ● D / SL | FB | | G |  |
L | | FI | PI | | Vitamin D3 Sandoz eco 1000 I.E. | 90 | 5.04 | 9.30 | 10% | | Weichkapseln: Cholecalciferolum 1000 UI | Sandoz Pharmaceuticals AG | ● D / SL | FB | | G |  |
L | | FI | PI | | Vitamin D3 Sandoz eco 3200 I.E. | 30 | 5.38 | 15.10 | 10% | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
L | | FI | PI | | Vitamin D3 Sandoz eco 3200 I.E. | 90 | 16.13 | 33.95 | 10% | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
L | | FI | PI | | Vitamin D3 Sandoz eco 25000 I.E. | 4 | 5.60 | 15.30 | 10% | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 90 mcg | 30 Einzeldosen | 15.60 | 33.40 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 90 mcg | 3 x 30 | 46.80 | 67.30 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 182 mcg | 30 Einzeldosen | 25.58 | 44.25 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 182 mcg | 3 x 30 | 76.74 | 99.90 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | | PS | Herceptin subkutan 600mg/5ml | | 1484.04 | 1630.40 | 10% | | Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
L | | FI | | | Ogivri 150 mg | | 456.84 | 513.25 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg | Medius AG | A / SL | FB | | G |  |
L | | FI | | I/B | Menveo | Kombipackung(en) | 31.69 | 50.90 | 10% | | Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg Pulver und Lösung (Durchstechflaschen): 3 Wirkstoffe | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | | I/B | Menveo | 5 Kombipackung(en) | 158.45 | 37.75 | 10% | | Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg Pulver und Lösung (Durchstechflaschen): 3 Wirkstoffe | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Imodium lingual akut | 10 | PA | PA | k.A. | | Schmelztabletten: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | PI | | Imodium lingual akut | 12 | PA | PA | k.A. | | Schmelztabletten: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | PI | | Nicorette Microtab Original-Aroma | 100 Tablette(n) | PA | PA | k.A. | | Sublingualtabletten: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | D3 VitaCaps 24,000 IU (600 μg) | 4 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | FI | PI | | D3 VitaCaps 24,000 IU (600 μg) | 8 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | FI | PI | | D3 VitaCaps 24,000 IU (600 μg) | 12 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | FI | PI | | Vitamin D3 Sandoz eco 25000 I.E. | 8 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | PI | | Vitamin D3 Sandoz eco 25000 I.E. | 12 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | | | Arnuity Ellipta 46 mcg | 30 | PA | PA | k.A. | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 46 µg | GlaxoSmithKline AG | B | FB | | G |  |
| | FI | PI | | Regaine 2 % | 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 2 % | 3 x 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 5 % | 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 5 % | 3 x 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | | | Mylotarg 5 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G |  |
|
| | FI | PI | | Minirin 0,1 mg | 30 Tablette(n) | 19.36 | 37.35 | 10% | | Tabletten: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Minirin 0,1 mg | 90 Tablette(n) | 63.69 | 85.30 | 10% | | Tabletten: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Minirin 0,2 mg | 30 Tablette(n) | 34.50 | 53.70 | 10% | | Tabletten: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Minirin 0,2 mg | 90 Tablette(n) | 110.77 | 136.20 | 10% | | Tabletten: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Nocutil | 5 ml | 34.21 | 53.60 | 10% | | Nasenspray: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Nocutil | 3 x 5 ml | 86.98 | 111.00 | 10% | | Nasenspray: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Nocutil 0,1 mg | 30 Tablette(n) | 17.42 | 35.35 | 10% | | Tabletten: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Nocutil 0,1 mg | 90 Tablette(n) | 57.32 | 78.75 | 10% | | Tabletten: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Nocutil 0.2 mg | 30 Tablette(n) | 31.05 | 50.20 | 10% | | Tabletten: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Nocutil 0.2 mg | 90 Tablette(n) | 99.69 | 124.85 | 10% | | Tabletten: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Octostim 15 ug | 10 1 Ampulle(n) à 1 ml | 257.92 | 296.90 | 10% | | Infusionslösung: Desmopressini Acetas 15 µg/ml | Ferring AG | B / SL | FB | | G |  |
| | FI | PI | | Minirin Melt 60 µg | 30 Tablette(n) | 19.36 | 37.45 | 10% | | Sublingualtabletten: Desmopressinum 60 µg | Ferring AG | B / SL | FB | | G |  |
| | FI | PI | | Minirin Melt 60 µg | 100 Tablette(n) | 70.76 | 93.35 | 10% | | Sublingualtabletten: Desmopressinum 60 µg | Ferring AG | B / SL | FB | | G |  |
| | FI | PI | | Minirin Melt 120 µg | 30 Tablette(n) | 34.50 | 53.95 | 10% | | Sublingualtabletten: Desmopressinum 120 µg | Ferring AG | B / SL | FB | | G |  |
| | FI | PI | | Minirin Melt 120 µg | 100 Tablette(n) | 123.07 | 150.25 | 10% | | Sublingualtabletten: Desmopressinum 120 µg | Ferring AG | B / SL | FB | | G |  |
| | FI | | | Minirin | 10 1 Ampulle(n) à 4 ug | PA | PA | k.A. | | Injektionslösung: Desmopressini Acetas 4 µg/ml | Ferring AG | B | FB | | G |  |
| | FI | PI | | Minirin | 6 ml | 38.66 | 60.80 | k.A. | | Nasenspray: Desmopressini Acetas | Ferring AG | B | FB | | G |  |
| | FI | PI | | Octostim | 2.5 ml | PA | PA | k.A. | | Nasenspray: Desmopressini Acetas 1.5 mg/ml | Ferring AG | B | FB | | G |  |